Frost & Sullivan Recognizes TATAA Biocenter's Complete, Best-in-Class Services for Analyzing Genetic Material

LONDON, Aug. 20, 2013 /PRNewswire/ -- Based on its recent research on the gene expression profiling services market, Frost & Sullivan presents TATAA Biocenter with the 2013 European Frost & Sullivan Award for Customer Value Leadership. TATAA Biocenter offers an end-to-end range of services for analyzing genetic material, from quantitative reverse transcription polymerase chain reaction (qRT-PCR) to nucleic acid extraction and sample preparation. Its services are sometimes coupled with hands-on training courses and commissioned research services such as assistance during experimental design and validation of kits, reagents and instruments of key market vendors.

LONDON, Aug. 20, 2013 /PRNewswire/ -- Based on its recent research on the gene expression profiling services market, Frost & Sullivan presents TATAA Biocenter with the 2013 European Frost & Sullivan Award for Customer Value Leadership. TATAA Biocenter offers an end-to-end range of services for analyzing genetic material, from quantitative reverse transcription polymerase chain reaction (qRT-PCR) to nucleic acid extraction and sample preparation. Its services are sometimes coupled with hands-on training courses and commissioned research services such as assistance during experimental design and validation of kits, reagents and instruments of key market vendors.

TATAA Biocenter has stayed ahead of the curve by offering a multitude of services such as extraction and purification of ribonucleic acid (RNA), microRNA (miRNA), deoxyribonucleic acid (DNA) and protein, microarray analysis, protein profiling and biostatistical analysis. Customers have the option of using services from a wide variety of instruments available from the most reputed vendors, including Roche, Life Technologies, Qiagen and Fluidigm.

"The center ensures that it validates the use of kits and reagents prior to offering services using the vendor's products," said Frost & Sullivan Senior Research Analyst Divyaa Ravishankar. "Frost & Sullivan research confirms that TATAA Biocenter is the only company that adheres to high quality standards in comparison to its competitors in Europe."

TATAA Biocenter's facility is known for its highly advanced infrastructure and trained laboratory personnel. It is one of the very first laboratories to have obtained ISO/IEC 17025:2005 flexible certification for qPCR analysis in Europe and recognition at an international level. Its numerous industrial collaborations help it stay up-to-date with the latest technologies and build up its extensive service expertise on the changing market needs and customer preferences.

In addition, TATAA Biocenter organises training programs which include world-class qPCR training that is offered in collaboration with international organizations. These programs are recognized by well-known institutions such as EMBO, FEBS, the Howard Hughes Medical Institute, UNESCO and Pittcon.

The center hosts lecture programs throughout the year and trainees and technicians have acclaimed them as some of the best in the world. Its workshops train attendees to design assays, conduct quality control of qPCR experiments, sample preparation and thresh out ways to derive highest quality results. The center also enables customers to design and optimize the setup costs and improve the output of results.

"TATAA Biocenter is a well-equipped, one-stop facility to perform all the steps of gene expression profiling, starting from sample preparation and extraction to qPCR and data analysis," noted Ms Divyaa Ravishankar. "It is the most advanced park in Europe, with 16 real-time PCR thermal cyclers from leading brands and has the capacity to support high throughput extraction and quality control."

The center also aims to disseminate knowledge on state-of-the-art technologies and know-how related to nucleic acid analysis to academic researchers. It offers seamless workflow from storage of samples, extraction, qPCR, analysis to downstream application. The risk of contamination is completely eliminated as it has individual facilities for each of the workflow processes.

Frost & Sullivan believes that TATAA Biocenter is best positioned to offer the most comprehensive range of services pertaining to nucleic acids. The main reasons for its superior performance include the strength of its offerings and educational programs, highest quality of service, strong vendor partnerships and infrastructure capabilities, and the overall acumen of its personnel.

Each year, Frost & Sullivan presents the Customer Value Leadership Award to a company that has demonstrated excellence in implementing strategies that proactively create value for its customers with a focus on improving the return on the investment that customers make in its services or products. The award recognizes the company's inordinate focus on enhancing the value that its customers receive, beyond simply good customer service, leading to improved customer retention and ultimately customer base expansion.

Frost & Sullivan's Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About TATAA Biocenter

TATAA Biocenter is world's largest organizer of hands-on training in quantitative real-time PCR (qPCR), Europe's leading provider of nucleic acid analysis services, and Sweden's most comprehensive distributor of products for nucleic acids analysis. TATAA Biocenter has the best equipped laboratories for qPCR based analysis in Europe, and provides contract research for a full range of nucleic acid analysis services, including primer and probe design, validation, quality control, profiling, data and pathway analysis, and kit and instrument evaluation to pharmaceutical and biotech companies. TATAA offers a seamless workflow, with all the instrumentation necessary for performing high quality experiments and for optimal sample handling, meeting the specific requirements for compliance with ISO17025 standard. TATAA core facility laboratories are also available for academic researchers. Founded in 2001, TATAA has permanent facility in Gothenburg, Sweden, and Prague, Czech Republic, and sales offices in Germany and USA.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

• The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
• The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact for more info:
Martin Cooke, TATAA Biocenter, Marketing & Comms Specialist.
Email: martin.cooke@tataa.com
 

TATAA Biocenter is leading provider of molecular services to the Advanced Therapies and Medical products (ATMP) industry in Europe and the Cell and Gene Therapy in the United States. With ISO 17025 accreditation and Good Laboratory and Clinical Practices (GLP/GCP) TATAA is perfectly positioned to support the pharmaceutical industry with biomarker profiling including genomics, transcriptomics, proteomics and microbiomics with traditional qPCR, dPCR and NGS methods as well as proprietary methods.

Tags: